Healthcare -
Biotechnology - NASDAQ - US
$ 115.69
1.08 %
$ 11.1 B
Market Cap
75.12
P/E
SRPT - CASH FROM OPERATIONS
Cash from Operations SRPT - Sarepta Therapeutics, Inc.
-501 M
LAST VALUE
-6.32%
2 YEAR CAGR
-5.21%
5 YEAR CAGR
-22.71%
10 YEAR CAGR